Haleon PLC Haleon 2024 Q1 Trading Statement
2024年5月1日 - 3:00PM
RNS Regulatory News
RNS Number : 7006M
Haleon PLC
01 May 2024
Haleon plc: 2024 Q1 Trading
Statement
1
May 2024: Haleon plc's Q1 trading
update for the year ended 31 December 2024 is available at:
http://www.rns-pdf.londonstockexchange.com/rns/7006M_1-2024-4-30.pdf.
The Q1 trading statement will also
be available on the Haleon website www.haleon.com/investors,
and the statement has been submitted in full unedited text to the
Financial Conduct Authority's National Storage Mechanism and will
shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Presentation
for analysts and shareholders:
A short presentation followed by Q&A will
be hosted by Tobias Hestler, Chief Financial Officer and Sonya
Ghobrial, Head of Investor Relations at 9:00am BST (10:00am CEST)
on 1 May 2024, which can be accessed at www.haleon.com/investors.
For analysts and shareholders wishing to ask
questions on the Q&A call, please use the dial-in details below
which will have a Q&A facility:
UK:
|
+44 800 279
3956
|
US:
|
+1 866 291 4166
|
All other:
|
+44 (0) 207 107 0613
|
Passcode:
|
43700369
|
An archived webcast of the Q&A call will be
available later on the day of the results and can be accessed at
www.haleon.com/investors.
About Haleon
Haleon (LSE / NYSE: HLN) is a global
leader in consumer health, with a purpose to deliver better
everyday health with humanity. Haleon's product portfolio spans
five major categories - Oral Health, Pain Relief, Respiratory
Health, Digestive Health and Other, and Vitamins, Minerals and
Supplements (VMS). Its long-standing brands - such as Advil,
Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident,
parodontax and Centrum - are built on trusted science, innovation
and deep human understanding.
For more information, please
visit www.haleon.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TSTSDDFWSELSELL
Haleon (LSE:HLN)
過去 株価チャート
から 6 2024 まで 7 2024
Haleon (LSE:HLN)
過去 株価チャート
から 7 2023 まで 7 2024